PHARMACOVIGILANCE AGREEMENTPharmacovigilance Agreement • August 5th, 2020
Contract Type FiledAugust 5th, 2020This Pharmacovigilance Agreement (this “Agreement”) is made and entered into as of [DATE] by and between Gelesis, Inc., a Delaware corporation with a business address of 501 Boylston Street, Suite 6102, Boston, MA 02116, USA (“Gelesis”) and CMS Bridging DMSS, a company organized under the laws of the United Arab Emirates with a business address of Unit No.: 205B, JBC1, Plot No.: JLT-PH1-G2A, Jumeirah Lakes Towers, Dubai, United Arab Emirates (“CMS”) Gelesis and CMS may be referred to herein collectively as the “Parties” and individually as a “Party.”